Adaptimmune Therapeutics PLC (ADAPY) Return on Capital Employed [ROCE] (2016 - 2025)
Adaptimmune Therapeutics (ADAPY) posted Return on Capital Employed [ROCE] of -176.89% for Q2 2025, down 139.80 percentage points from -37.08% a year earlier and down 133.67 percentage points from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics PLC (ADAPY) Return on Capital Employed [ROCE] (2016 - 2025) Analysis & Trends
For FY2024, Adaptimmune Therapeutics' Return on Capital Employed [ROCE] came in at -34.42%, up 25.56 percentage points from FY2023.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +37.33 percentage points (FY2019 to FY2024).
- In prior years, Adaptimmune Therapeutics' Return on Capital Employed [ROCE] was -59.98% in FY2023 (-11.00 pp), -48.98% in FY2022 (-8.20 pp), -40.79% in FY2021 (+7.33 pp) and -48.11% in FY2020 (+23.64 pp).
- The Q2 2025 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2016.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of -6.68 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2020, with a gain of 55.74 percentage points; the weakest was Q2 2025, with a drop of 139.80 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -43.22% (Q1 2025), -31.66% (Q4 2024) and -17.61% (Q3 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -176.89% |
| Mar 31, 2025 | -43.22% |
| Dec 31, 2024 | -31.66% |
| Sep 30, 2024 | -17.61% |
| Jun 30, 2024 | -37.08% |
| Mar 31, 2024 | -93.50% |
| Dec 31, 2023 | -64.44% |
| Sep 30, 2023 | -47.87% |
| Jun 30, 2023 | -47.40% |
| Mar 31, 2023 | -45.87% |
| Dec 31, 2022 | -61.63% |
| Sep 30, 2022 | -61.05% |
| Jun 30, 2022 | -54.11% |
| Mar 31, 2022 | -46.06% |
| Dec 31, 2021 | -46.49% |
| Sep 30, 2021 | -47.47% |
| Jun 30, 2021 | -41.92% |
| Mar 31, 2021 | -35.38% |
| Dec 31, 2020 | -31.32% |
| Sep 30, 2020 | -27.40% |
API Access
Adaptimmune Therapeutics PLC Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();